TrialA Study to Evaluate the Long Term Safety of OTX-TP (Sustained Release Travoprost) Intracanalicular Insert
Trial details
- Registry ID
- NCT04061044
- Phase
- Phase 3
OCUL
Ocular Therapeutix, Inc.
Company identity checked against sources
Browse linked trials and recorded changes, or follow this company for updates.
8Trials in this database
2Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity sourceA Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
Trial details
- Registry ID
- NCT04539548
- Phase
- Phase 3
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
Trial details
- Registry ID
- NCT05335122
- Phase
- Phase 2
OTX-DED for the Short-term Treatment of the Symptoms of Dry Eye Disease (DED)
Trial details
- Registry ID
- NCT05814757
- Phase
- Phase 2
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration
Trial details
- Registry ID
- NCT06223958
- Phase
- Phase 3
Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration
Trial details
- Registry ID
- NCT06495918
- Phase
- Phase 3
A Study to Evaluate the Efficacy and Safety of OTX-TKI (Axitinib Implant) in Participants With Non-Proliferative Diabetic Retinopathy
Trial details
- Registry ID
- NCT07235085
- Phase
- Phase 3
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
Trial details
- Registry ID
- NCT07516132
- Phase
- Phase 3
Latest recorded trial changes
Study to Evaluate Long-Term Safety of Intravitreal OTX-TKI (Axitinib Implant) in Participants With Neovascular Age-Related Macular Degeneration Who Successfully Completed 2-Year OTX-TKI-2023-AMD-301 or OTX-TKI-2023-AMD-303 Study
NCT07516132 · Ocular Therapeutix, Inc.
Recruitment status changed
− Before
Not yet recruiting
+ After
Recruiting
A Study to Evaluate the Efficacy and Safety of OTX-TIC (Travoprost) Intracameral Implant for Patients With Open-angle Glaucoma (OAG) or Ocular Hypertension (OHT)
NCT05335122 · Ocular Therapeutix, Inc.
Main study measure wording changed
Text changed; whether the study measures changed has not been verified. Saved text may be shortened.
Compare wording
− Before
Measure: Efficacy Outcome: IOP changes from Baseline
+ After
Measure: IOP Changes From Baseline in the Study Eye